HC Wainwright Weighs in on Acurx Pharmaceuticals, Inc.’s FY2028 Earnings (NASDAQ:ACXP)
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Free Report) – HC Wainwright issued their FY2028 earnings estimates for shares of Acurx Pharmaceuticals in a report issued on Tuesday, March 19th. HC Wainwright analyst E. Arce expects that the company will post earnings per share of ($4.13) for the year. HC Wainwright has a “Buy” rating and a […]
More Stories
Evans Bancorp (NYSEAMERICAN:EVBN) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Evans Bancorp (NYSEAMERICAN:EVBN – Free Report) in a research note released on Monday. The...
Inuvo (NYSE:INUV) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Inuvo (NYSE:INUV – Free Report) in a research note released on Sunday morning. The...
Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Sunday. The firm issued...
StockNews.com Initiates Coverage on Carver Bancorp (NASDAQ:CARV)
StockNews.com began coverage on shares of Carver Bancorp (NASDAQ:CARV – Free Report) in a research report report published on Monday....
Profire Energy (NASDAQ:PFIE) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Profire Energy (NASDAQ:PFIE – Free Report) in a report released on Sunday morning. The...
ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (NYSEARCA:QULL) Stock Price Down 0.4% – Here’s Why
ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (NYSEARCA:QULL – Get Free Report) shares traded down 0.4% during trading...